Cypress Capital Management (Delaware)’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,540
| Closed | -$239K | – | 159 |
|
|
2018
Q4 | $239K | Hold |
6,540
| – | – | 0.05% | 137 |
|
|
2018
Q3 | $318K | Sell |
6,540
-100
| -2% | -$4.86K | 0.06% | 128 |
|
|
2018
Q2 | $286K | Hold |
6,640
| – | – | 0.05% | 127 |
|
|
2018
Q1 | $278K | Sell |
6,640
-280
| -4% | -$11.7K | 0.05% | 123 |
|
|
2017
Q4 | $301K | Hold |
6,920
| – | – | 0.06% | 121 |
|
|
2017
Q3 | $294K | Sell |
6,920
-350
| -5% | -$14.9K | 0.06% | 111 |
|
|
2017
Q2 | $313K | Sell |
7,270
-1,450
| -17% | -$62.4K | 0.07% | 97 |
|
|
2017
Q1 | $365K | Sell |
8,720
-360
| -4% | -$15.1K | 0.09% | 83 |
|
|
2016
Q4 | $355K | Sell |
9,080
-46,215
| -84% | -$1.81M | 0.09% | 79 |
|
|
2016
Q3 | $2.44M | Sell |
55,295
-2,290
| -4% | -$101K | 0.78% | 36 |
|
|
2016
Q2 | $2.41M | Sell |
57,585
-2,580
| -4% | -$108K | 0.81% | 37 |
|
|
2016
Q1 | $2.42M | Sell |
60,165
-810
| -1% | -$32.6K | 0.82% | 39 |
|
|
2015
Q4 | $3.12M | Buy |
60,975
+25,535
| +72% | +$1.31M | 0.93% | 39 |
|
|
2015
Q3 | $1.66M | Buy |
35,440
+22,000
| +164% | +$1.03M | 0.53% | 42 |
|
|
2015
Q2 | $838K | Buy |
13,440
+1,600
| +14% | +$99.8K | 0.24% | 46 |
|
|
2015
Q1 | $731K | Buy |
11,840
+340
| +3% | +$21K | 0.22% | 45 |
|
|
2014
Q4 | $621K | Buy |
11,500
+2,820
| +32% | +$152K | 0.18% | 45 |
|
|
2014
Q3 | $460K | Buy |
8,680
+2,760
| +47% | +$146K | 0.14% | 40 |
|
|
2014
Q2 | $307K | Buy |
+5,920
| New | +$307K | 0.09% | 44 |
|